Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Application of Fetal Stem Cells in Diabetes: Iran’S Experience



Tootee A1 ; Nasli Esfahani E1 ; Larijani B1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Public Health Published:2015

Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Application of Allotransplantation of Fetal Liver-Derived Stem-Cells for Treatment of Type 1 Diabetes: A Single-Arm, Phase 3 Clinical Trial, Iranian Journal of Public Health (2015)
2. Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations, Medical Journal of the Islamic Republic of Iran (2022)
3. Transitional Meningioma After Fetal Liver-Derived Cell Suspension Allotransplant: A Case Report, Experimental and Clinical Transplantation (2017)
4. Stem Cells Researches and Therapies Towards Endocrine Diseases Treatment; Strategies, Challenges, and Opportunities, Journal of Diabetes and Metabolic Disorders (2021)
5. Investigating the Safety and Efficacy of Hematopoietic and Mesenchymal Stem Cell Transplantation for Treatment of T1dm: A Systematic Review and Meta-Analysis, Systematic Reviews (2022)
6. Stem Cell Therapy for Patients With Diabetes: A Systematic Review and Meta-Analysis of Metabolomics-Based Risks and Benefits, Stem Cell Investigation (2018)
7. Endocrinology and Metabolism Institute Over Time: A Quarter of a Century of Experience, Iranian Journal of Diabetes and Metabolism (2021)
8. Endocrinology and Metabolism Research Institute From Inception to Maturity: An Overview of 25-Year Activity, Journal of Diabetes and Metabolic Disorders (2020)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (19)
Ensieh Nasli Esfahani (8)
Other Related Docs
9. Evaluation of Fetal Cell Transplantation Safety in Treatment of Diabetes: A Three-Year Follow-Up, Journal of Diabetes and Metabolic Disorders (2015)
10. Insulin Independence After Fetal Liver-Derived Cell Suspension Allotransplantation in Patients With Type 1 Diabetes: A Pilot Study, Iranian Journal of Public Health (2015)
11. Stem Cell-Based Approach for the Treatment of Parkinson's Disease, Medical Journal of the Islamic Republic of Iran (2015)
12. Safety and Efficacy of Hematopoietic and Mesanchymal Stem Cell Therapy for Treatment of T1dm: A Systematic Review and Meta-Analysis Protocol, Systematic Reviews (2018)
13. The Effect of Fetal Liver-Derived Cell Suspension Allotransplan-Tation on Patients With Wolfram Syndrome: The First Year of Fol-Low-Up, Iranian Journal of Public Health (2015)
14. Assessment of Immune-Alternations and Their Correlations With Therapeutic Outcomes of Transplantation of Autologous Mesenchymal and Allogenic Fetal Stem Cells in Patients With Type 1 Diabetes: A Study Protocol, Journal of Diabetes and Metabolic Disorders (2021)
15. Mesenchymal Stem Cell Transplantation in Newly Diagnosed Type-1 Diabetes Patients: A Phase I/Ii Randomized Placebo-Controlled Clinical Trial, Stem Cell Research and Therapy (2022)
16. Therapy of Endocrine Disease: Islet Transplantation for Type 1 Diabetes: So Close and yet so Far Away, European Journal of Endocrinology (2015)
17. Albuminuria in Diabetic Patients Before and After Fetal Liver-Derived Cell Suspension Allotransplantion: A 24 Months Follow up Study, Iranian Journal of Public Health (2015)
18. Administration of Autologous Mesenchymal Stem Cell Transplantation for Treatment of Type 1 Diabetes Mellitus, Iranian Journal of Public Health (2015)
19. Achievements and Advances in Diabetes Research Over a Quarter of a Century: A Review of the Available Evidence, Iranian Journal of Diabetes and Metabolism (2021)
20. Stem Cell Transplantation in Iran: A Systematic Review Article, Iranian Journal of Public Health (2015)
21. An Overview of Diabetes Research Achievements During a Quarter of a Century in Diabetes Research Center, Journal of Diabetes and Metabolic Disorders (2021)
22. Generation of High Yield Insulin-Producing Cells (Ipcs) From Various Sources of Stem Cells, Vitamins and Hormones (2021)
23. The Most Ideal Pancreas Extracellular Matrix As a Platform for Pancreas Bioengineering: Decellularization/Recellularization Protocols, Advances in Experimental Medicine and Biology (2021)